|
Volumn 359, Issue 9303, 2002, Pages 357-358
|
Treatment of cervical cancer [8] (multiple letters)
d
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
FLUOROURACIL;
HYDROXYUREA;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
COLORECTAL CANCER;
CONTROLLED STUDY;
DIARRHEA;
DRUG CHOICE;
DRUG EFFECT;
ENZYME DEFICIENCY;
HUMAN;
HYPERTHERMIC THERAPY;
LETTER;
MAXIMUM PERMISSIBLE DOSE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION ENTEROPATHY;
UTERINE CERVIX CANCER;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
FEMALE;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NOTE;
SURVIVAL RATE;
UTERINE CERVIX TUMOR;
MIDDLE AGED;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
RADIOTHERAPY, ADJUVANT;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
ADULT;
AGED;
MIDDLE AGED;
|
EID: 0037176527
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)07518-9 Document Type: Letter |
Times cited : (5)
|
References (5)
|